Dept. of Biomedical Science, Missouri State Univ., Springfield, 65897, USA.
Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1146-54. doi: 10.1152/ajpheart.00252.2009. Epub 2010 Feb 5.
The importance of gonadal hormones in the regulation of vascular function has been documented. An alternate and essential contribution of the sex chromosomes to sex differences in vascular function is poorly understood. We reported previously sex differences in microvessel permeability (P(s)) responses to adenosine that were mediated by the cAMP signaling pathway (Wang J, PhD thesis, 2005; Wang J and Huxley V, Proceedings of the VIII World Congress of Microcirculation, 2007; Wang J and Huxley VH, Am J Physiol Heart Circ Physiol 291: H3094-H3105, 2006). The two cyclic nucleotides, cAMP and cGMP, central to the regulation of vascular barrier integrity, are hydrolyzed by phosphodiesterases (PDE). We hypothesized that microvascular endothelial cells (EC) would retain intrinsic and inheritable sexually dimorphic genes with respect to the PDEs modulating EC barrier function. Primary cultured microvascular EC from skeletal muscles isolated from male and female rats, respectively, were used. SRY (a sex-determining region Y gene) mRNA expression was observed exclusively in male, not female, cells. The predominant isoform among PDE1-5, present in both XY and XX EC, was PDE4. Expression mRNA levels of PDE1A (male > female) and PDE3B (male < female) were sex dependent; PDE2A, PDE4D, and PDE5A were sex independent. Barrier function, P(s), was determined from measures of albumin flux across confluent primary cultured microvessel XY and XX EC monolayers. Consistent with intact in situ microvessels, basal monolayer P(s) did not differ between XY (1.7 +/- 0.2 x 10(-6) cm/s; n = 8) and XX (1.8 +/- 0.1 x 10(-6) cm/s; n = 10) EC. Cilostazol, a PDE3 inhibitor, reduced (11%, P < 0.05) P(s) in XX, not XY, cells. These findings demonstrate the presence and maintenance of intrinsic sex-related differences in gene expression and cellular phenotype by microvascular EC in a gonadal-hormone-free environment. Furthermore, intrinsic cell-sex likely contributes significantly to sexual dimorphism in cardiovascular function.
性腺激素在血管功能调节中的重要性已得到证实。性染色体对血管功能性别差异的另一种重要但尚未被充分理解的贡献。我们之前报道过,微脉管通透性(P(s))对腺苷的反应存在性别差异,这些差异是通过 cAMP 信号通路介导的(Wang J,博士论文,2005;Wang J 和 Huxley V,第八届世界微循环大会论文集,2007;Wang J 和 Huxley VH,Am J Physiol Heart Circ Physiol 291:H3094-H3105,2006)。两种环核苷酸,cAMP 和 cGMP,是血管屏障完整性调节的核心,它们被磷酸二酯酶(PDE)水解。我们假设,微血管内皮细胞(EC)将保留与调节 EC 屏障功能的 PDE 相关的内在和可遗传的性别二态基因。分别使用来自雄性和雌性大鼠的骨骼肌分离的原代培养的微血管 EC。仅在雄性细胞中观察到性别决定区域 Y 基因(SRY)mRNA 的表达,而在雌性细胞中则没有。在 XY 和 XX EC 中均存在的 PDE1-5 中的主要同工酶是 PDE4。PDE1A(雄性>雌性)和 PDE3B(雄性<雌性)的 mRNA 表达水平存在性别依赖性;PDE2A、PDE4D 和 PDE5A 则无性别依赖性。屏障功能,P(s),是通过测量在连接的原代培养的微血管 XY 和 XX EC 单层上的白蛋白通量来确定的。与完整的原位微血管一致,XY(1.7 +/- 0.2 x 10(-6) cm/s;n = 8)和 XX(1.8 +/- 0.1 x 10(-6) cm/s;n = 10)EC 之间的基础单层 P(s) 没有差异。西洛他唑,一种 PDE3 抑制剂,降低了 XX(11%,P < 0.05)而不是 XY 细胞的 P(s)。这些发现表明,在没有性腺激素的环境中,微血管 EC 存在并维持内在的与性别相关的基因表达和细胞表型差异。此外,内在的细胞性别可能对心血管功能的性别二态性有重要贡献。